kaiser permanente glp-1 coverage news IBX members face drug costs after insurance change Medicaid Coverage of and Spending
Description
J Clin Invest 121(5):19171929
These findings suggest that survodutide has the potential to reduce liver fibrosis and improve liver function in patients with NASH, making it a promising therapeutic option for this complex liver disease [89]
doi: 10.4103/NRR.NRR-D-23-01910
Absence of evidence is not evidence of absence
In animal models SGLT2 inhibitors have been theorized to potentially increase risk of MTC
Mori, K., Nagao, H
